VAM
ABBV icon

Verity Asset Management’s AbbVie ABBV Stock Holding History

Verity Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Sell
2,707
-131
-5% -$28.2K 0.26% 105
2026
Q1 		$617K Buy
2,838
+20
+0.7% +$4.44K 0.26% 107
2025
Q4 		$644K Buy
2,818
+156
+6% +$35.5K 0.28% 103
2025
Q3 		$616K Sell
2,662
-2
-0.1% -$407 0.2% 113
2025
Q2 		$494K Buy
2,664
+305
+13% +$56.7K 0.24% 108
2025
Q1 		$494K Buy
2,359
+261
+12% +$50.7K 0.2% 115
2024
Q4 		$360K Buy
2,098
+344
+20% +$63.2K 0.2% 111
2024
Q3 		$347K Buy
1,754
+116
+7% +$21.6K 0.13% 141
2024
Q2 		$281K Buy
1,638
+148
+10% +$24.5K 0.11% 152
2024
Q1 		$271K Sell
1,490
-1
-0.1% -$172 0.15% 156
2023
Q4 		$231K Buy
+1,491
New +$217K 0.15% 161

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Verity Asset Management's ABBV Position: Q2 2026 in Review

Verity Asset Management reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $28.2K and leaving 2,707 shares worth $681K. The position accounts for 0.26% of the portfolio, ranked #105.

Verity Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Verity Asset Management held 2,707 shares of AbbVie worth $681K as of Q2 2026.
  • Verity Asset Management sold 131 AbbVie shares in Q2 2026, an estimated $28.2K.
  • AbbVie made up 0.26% of Verity Asset Management's portfolio in Q2 2026, its #105 holding.
  • Verity Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.